Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025
Medical and Pharmaceutical bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans The University of California says 15 veterans die from lung cancer around the world every day Rowan DunneOctober 9, 2024